Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > This Morning's Carlyle Group Conference Call

<< Previous

Bullboard Posts

Next >>

Post by gebremeskelon Aug 05, 2024 1:57pm

230 Views

Post# 36164822

This Morning's Carlyle Group Conference Call

I didn't hear anything about a Vantive buyout deal but the focus of the call was Q2 financial results with limited information about what is in the works for the second half of 2024. But maybe I missed something - they have a lot of irons in the fire. Hopefully Baxter will talk about the potential deal tomorrow morning.

Here is the link to the Carlyle call:

https://ir.carlyle.com/events/event-details/carlyle-group-second-quarter-2024-earnings-call

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China